JERSEY CITY - SCYNEXIS, Inc. (NASDAQ: SCYX), a clinical-stage biotechnology company advancing novel therapies for severe rare diseases, announced completion of a Phase 1 study of SCY-770, a ...
Perth-based company PYC Therapeutics will take early human data on its polycystic kidney disease drug to the American Society of Nephrology conference in Denver on 22 October.
12h
PYC Therapeutics Shares Slide Nearly 8% as Biotech Gives Back Gains Ahead of Key Kidney Disease Data
PYC Therapeutics shares fell nearly 8% amid heightened volatility, with investors focused on upcoming safety and efficacy data for its experimental treatment for inherited kidney disease.
Researchers led by Dr. Ralph Witzgall, a professor at the Chair of Molecular and Cellular Anatomy at the University of ...
Travis Barker is giving fans a health update, with the Blink-182 drummer sharing new photos from an apparent hospitalization.
"Rocky" franchise star Dolph Lundgren was considering ending his life after a yearslong battle with kidney cancer. A second ...
Panelists discuss how recent data from the KEYNOTE-564 trial has changed their approaches to treating patients with renal cell carcinoma by implementing adjuvant pembrolizumab therapy for high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results